Thank you for submitting your manuscript for consideration by the EMBO Journal. It has now been seen by three referees whose comments are enclosed. As you will see, all three referees express interest in your work, but all also raise a number of significant concerns that would need to be addressed before we can consider publication.
Their reports are explicit, so I see little need to go into details here. One thing I would highlight, though, is that I share referee 3's alarm about the duplication of images between figure 4 here and figure 5 of your recent EJCB paper. While I recognise that these panels are largely there as a control, it is not permissible to re-use images, and they will need to be replaced with appropriate controls that match the experiments done for this figure. I also share referee 3's concern about various overstatements throughout the text: it will be important to tone down some of the conclusions. In addition, the referees also make a number of valuable suggestions for additional experimental analysis -both in terms of important controls, as well as some further reaching experiments -which I would strongly encourage you to follow.
The manuscript by Schwintzer et al describes the characterization of the interaction between Syndapin I and Cobl. It was a great pleasure to read about the biochemical analysis of this interaction since the authors performed the experiments with great care and included all the necessary controls. They found that endogenous Cobl and Syndapin coimmunoprecipitate and mapped the interaction to the SH3 domain of Syndapin and the N-terminus of Cobl: They identified three conserved class I SH3 binding sites in Cobl and show that a peptide with this consensus motif can interact with the SdpI SH3 domain. Furthermore, fragments harbouring individual sites are sufficient for a direct interaction with the SdpI SH3 domain. Schwintzer et al provide evidence that full length Sdp1 but not the SH3 domain of SdpI alone can recruit Cobl to liposomes suggesting that the F-BAR domain (located in the N-term of SdpI) might be required for this recruitment. The authors also show that endogenous Syndapin I and Cobl colocalize in structures resembling synapses along dendrites of primary neurons. The authors had shown previously that both Cobl and SdpI overexpression causes an increase in number and branching of dendrites of hippocampal neurons. In this manuscript they extend these findings by providing evidence that co-overexpression further increases dendritic branching and that the increase caused by overexpression of Cobl is dependent on SdpI providing a functional explanation for the novel interaction between both proteins. Overall this is a very interesting study, however, I can only recommend publication in the EMBO J after answering the specific comments and after the following controls have been made.
Specific comments:
1) The authors had shown previously that SdpI and N-WASP interact and that the SdpI overexpression phenotype is dependent on N-WASP (Dharmalingam et al J. Neurosci. 2009 ). Is there a trimolecular complex of SdpI, Cobl, and N-WASP? Do they cooperate?
2) Is there a role for SdpI and Cobl in axon branching (In contrast to dendrite branching here SdpI and Cobl appear to have opposing roles as published by the authors previously: SdpI knockdown increased axon branching and Cobl overexpression increased axon branching (Ahuja et al, 2007 Cell; Dharmalingam et al J. Neurosci. 2009 ). Alternatively, does SdpI cooperate with N-WASP in one process (e.g. axon branching) and in dendrites SdpI cooperates with Cobl?
3) Does SdpI activate Cobl dependent F-actin nucleation (as has been shown by the authors for SdpI and N-WASP)? 4) Fig. 5 : Page 9-10 The Cobl 319-396 harbours 7 putative SH3 binding sites and the authors show convincingly that the class one SH3 motif repeated 3 times in the Cobl N-terminus is sufficient for interaction with the SH3 domain of SdpI. However, this does not exclude the possibility that the other SH3 binding sites can contribute to this interaction. Either the authors need to generate a deletion construct of Cobl with the 3 SH3 binding sites deleted or they should tone down their statement. Fig. 6 ; page 10: The distribution of SdpI added alone to liposomes has been published and should be cited in the results section and not only in the discussion. Furthermore, it is standard in the field to repeat experiments three times ("...Quantitative analysis of blots from two different experiments...". (Fig 8J) ), how can it suppress branching induced by Cobl?
5)
Referee #3 (Remarks to the Author):
The manuscript "The functions of the actin nucleator cobl in cell morphology control critically depend on syndapin" by Schwintzer et al. characterizes the interaction of cobl with syndapins and the importance of this interaction for cell morphology.
The presented data are interesting in terms of the link of cobl to syndapin and the functional implications of this interaction. The experimental evidence for cobl and syndapin interaction looks convincing and the experiments were performed carefully. This manuscript is based on findings reported in Ahuja et al. (2007) and Kessel et al. (2010) , however I consider the sum of presented data here as sufficiently novel for publication in EMBO J.. The interactions of syndapin and cobl are explained in detail and a role of this complex in cell morphology is proposed.
One major criticism I have concerns the style of the manuscript. The tone must be tuned down! It starts with the title, which I had to read several times to understand the structure of the sentence. Why 'in cell morphology control' and not simply 'cell morphology'? Throughout the entire manuscript every statement is played to the extreme. Examples: Abstract -'both proteins are crucial for dendritogenesis' -are they crucial if dendrite formation is altered by 10-20%? Abstract -'These data provide detailed insights into the the cobl-mediated functions indispensable for neuronal network formation' -indispensable for what? The null neurons look o.k. to me ... Introduction -'Drastic alterations of cell morphology ...'?? 'Of outmost importance ...' ?? ' ... we reveal by extensive in vitro and in vivo studies ...' Results (page 6) -'In order to address whether the newly discovered Cobl/syndapin interaction ...' -why newly discovered? The interaction was described by Ahuja et al. and is the basis of the current manuscript!? The use of 'dramatic' attributes continues throughout the following text. I understand that the authors want to highlight the importance of their results, but the reader is a bit put off by the exaggerated wording. I strongly suggest that the authors tune down the tone and take out all the unnecessary filling phrases and attributes. This will not diminish the quality of data or the appreciation of the reader for the data.
Second the discussion must be condensed. The empty RFP vector alone is not a convincing control (no unrelated siRNA is expressed as far as I understand ...). Since the effects are very small (around 11% !), I could claim that such a small effect would be caused by any unrelated siRNA -were is then the specificity ? Page 9, Fig.5 : '.. breaking the cobl 319-396 into two fragments revealed that... syndapin has at least two binding sites in this region'. I don't find that this is a justified conclusion. It could simply be one binding site which after splitting has retained sufficient affinity on both fragments. Although it is technically difficult to express Cobl in primary hippocampal neurons, we additionally have made considerable efforts during the three months of the revision to conduct the experiment the reviewer suggested, i.e a comparison of a Cobl RNAi rescue with wild-type Cobl versus a rescue attempt with a Cobl mutant lacking syndapin-binding. The two conditions indeed seemed to differ: while it has already been published that coexpression of GFP-Cobl wild-type rescues the two Cobl RNAi phenotypes (Ahuja et al., 2007) , GFPCoblΔCobl Homology coexpression did not seem to rescue. However, the summarized n-numbers across all assays we obtained were not high enough to drive the data into statistical significance using ANOVA testing. Therefore, we were not able to include these data sets into the revised manuscript. As an information to the reviewer we here include a figure summarizing the current data:
If possible, the role of syndapin I in the modulation of actin nucleation activity of Cobl would be quantified by in vitro assays such as pyrene actin assay.
We agree with the reviewer that some in vitro-reconstitutions of the processes we extensively studied in vivo would be desirable. However, as already eluted to in the primary characterization of Cobl (Ahuja et al., 2007) an in several international presentations of our work, despite extensive past and ongoing efforts of our and of other labs, it is thus far not possible to purify larger amounts of Cobl full-length. Low expression, protein degradation and insolubility preclude this.
The essential point is on whether syndapin is the major regulator of Cobl or not. Thus, it is very helpful to understand the abundance of syndapin among cobl Nterminal domain binding proteins. The GST-fusion Cobl N-terminal domain pull down assay using brain lysate will identify major interactors of Cobl N-terminal domain in brain.
The Cobl Homology domain we identified as syndapin-binding interface is defined by the presence of three peculiar motifs with the consensus KrRAPpPP. We have shown that these conserved motifs are syndapin binding sites. We acknowledge that the question of the reviewer is very interesting, as it may lead to insights into putative cross-talk of protein interactions within the largely unknown molecular machinery built around the actin nucleator Cobl. We have therefore purified a GST fusion protein of a Cobl Homology domain-defining motif, immobilized it on glutathione sepharose and incubated it with TRITON X-100 extracts of brain lysates. In the eluates we aimed for comparing the intensities of bands of the different putative binding partners, as the reviewer suggested. Critical analyses of the trace bands seen by the Cobl fusion protein alone and of the unspecific bands obtained by the GST control with and without addition of brain extract revealed only one specific band in the pull-downs with the GST Cobl fusion proteins. Importantly, this single specific band clearly was the major band and corresponded to the size of syndapin (revised Figure 5P -Q).
Western blot analysis with anti-syndapin I antibodies indeed confirmed the presence of syndapin I in the band (revised Figure 5R) . Thus, at least in the brain, syndapin I seems to be a major binding partner.
Referee #2 (Remarks to the Author):
The SdpI, Cobl, and N-WASP? This is a very interesting question, albeit technically difficult to address. We have affinitypurified a set of different antibodies for coimmunoprecipitation analyses. We are proud to now present coimmunoprecipitation analyses of endogenous Cobl/syndapin I/N-WASP complexes (revised Figure 8O ). As the analyses were done with anti-Cobl antibodies and as we do not have any hints on direct Cobl/N-WASP interactions, these analyses strongly suggest that Cobl, syndapin I and N-WASP are indeed present in one complex in the brain.
Do they cooperate?
This seemed possible. We therefore decided to address a putative functional cooperativity of Arp2/3 complex-and Cobl-mediated actin nucleation by asking directly, whether Coblmediated dendritic arbor formation may not only involve Arp2/3 complex activation but even rely on this pathway. During the revision period we indeed succeeded in obtaining enough Cobl and Arp3 RNAi double-transfected neurons for quantitative analyses in our weekly assays: The data obtained for Arp3 RNAi very much resembled those of syndapin I RNAi, i.e. both Coblmediated dendritegenesis and dendrite branching were effectively suppressed (revised Figure 8 M and N). While both the Arp2/3 complex and Cobl do not rely on each other mechanistically during actin nucleation (Ahuja et al., 2007) , these experiments demonstrate that Cobl indeed functionally interfaces with Arp2/3-mediated actin nucleation during neuromorphogenesis.
Considering that such a syndapin-mediated interconnection of Cobl with the Arp2/3 complex activator N-WASP will require both the SH3 domain and the dimerizing F-BAR domain of syndapin and that the F-BAR domain is the lipid-binding moiety of syndapin I (when dimerized) it seemed likely that such a functional cooperation especially takes place at the plasma membrane and helps to shape cells. In order to address whether the overexpression phenotype of Cobl-CT represents a gain-offunction phenotype, we made additional efforts to express Cobl full-length in young neurons. Whereas more standard methods failed, we were able to obtain some Cobl overexpressing cells by electroporation. Quantitative comparisons of neurons transfected with GFP-Cobl full-length with control cells showed that there was no difference in early axon development. These data suggest that the Cobl-CT effect is not a gain-of-function phenotype. Thus, it seems somewhat unlikely that in the axon, syndapin I and Cobl have opposing roles -instead it remains to be seen whether Cobl has some role in axonal development at all. Therefore, and also because opposite roles would be in contrast to the situation in the dendritic compartment where our data clearly show that Cobl and syndapin I work together, we would agree with the reviewer that the WASP/Arp functions mediated by syndapin in axon development probably are Cobl-independent.
In line with this, we also did not obtain data showing a Cobl-dependence of N-WASPmediated neuronal morphology changes (data not shown). The (probably compartimentalized) cooperativity of Cobl and the Arp2/3 complex in the physiological process of dendrite formation and branching are now discussed in the revised manuscript.
3) Does SdpI activate Cobl dependent F-actin nucleation (as has been shown by the authors for SdpI and N-WASP)?
We agree with the reviewer that some in vitro-reconstitutions of the processes we extensively studied in vivo would be desirable. However, as already eluted to in several international presentations of our work, despite extensive past and ongoing efforts of our and or other labs, it is thus far not possible to purify larger amounts of Cobl full-length, as low expression, protein degradation and insolubility preclude this. Fig. 5 The reviewer is correct. We did not provide evidence that indeed each of the three KrRAPpPP-motifs represents a syndapin SH3 domain motif but just demonstrated that three short stretches harbouring these motifs bind and for one of the motifs showed exemplarily that this represents a SH3 domain binding site.
4)
The reviewer is also stressing that besides the two sites that we identified as syndapinbinding consensus in Cobl 319-396 (KRRAPPPP and KRRAPAPP), there are further putative SH3 binding sites in Cobl 319-396 located C-terminal of the KRRAPPPP and the KRRAPAPP motifs. These are PQQP, PPSP, and PVVPNRK and at least two of these show conserved PxxP-residues among mammalian species (PPSP is absent in dog, see Figure  S4 ). As also seen from Fig. S4 , however, none of these motifs is conserved in chicken, frog and fish. In contrast, the KRRAPPPP and the KRRAPAPP motif are conserved in Cobl orthologs of all species. In order to address the reviewers concerns we therefore conducted two different sets of experiments. 1) We deleted the residues 323-366 and thereby were able to directly test a putative binding to the proline-rich motifs C-terminal of KrRAPpPP-motifs #3 (between KrRAPpPP-motif #2 and 3 there are no further putative binding sites (see Figure 5I) ). Additionally, we used a Cobl deletion mutant spanning the residues 367-713 (does not include a complete PQQP but includes the PPSP and PVVPNRK motifs) to start to address which of the three additional PxxP-motifs the revierwer pointed out may interact with syndapin. However, both constructs failed to bind (revised Figure 5J -L).
2) We cloned all three individual KrRAPpPP-motifs and demonstrated their binding to the syndapin SH3 domain (please see revised Figure 5M -O).
Together these experiments in our eyes now clearly demonstrate that the three KrRAPpPPconsensus motifs are the syndapin binding sites and that other PxxP-motifs located elsewhere in the extended proline-rich domains of Cobl do not bind to syndapin. 
Furthermore, it is standard in the field to repeat experiments three times ("...Quantitative analysis of blots from two different experiments...".
The liposome assay with syndapin I and GFP-Cobl 1-713 and syndapin I SH3 + GFP-Cobl 1-713, respectively, has been repeated two more times (the revised manuscript thus reports on n = 4 independent biochemical assays). The quantitative determination of the blot signals in the revised Figure 6C now displays the data of the increased n-number. The result (75.6 vs. 5.2%) is similar to the averages shown in the previous figure (the strong difference slightly increased even further) (revised Figure  6C) .
6) Fig. 6: B Cobl 1-73 should read Cobl 1-713 ?? In C it should read Cobl 1-713 instead of 1-715 ??
Correct. Thank you very much for noticing these errors! Both typos have been corrected in the revised Figure 6 .
7) Fig. 4 I: It would be better to show the numbers of dendrites and not % deviation from control. Is the difference between GFP and GFP-Cobl & SdpI overeexpression significant? The appropriate statistical test would be One Way ANOVA and not t-test.
The absolute numbers of dendrites for the different transfections are not shown because each and every assay is based on comparison to an in-assay GFP-control to minimize putative variation that are simply due to primary cell preparation and culturing. Therefore % deviation from control and not the absolute numbers was chosen for reporting the data. Thank you for your hint on the appropriate statistical test for the data in 
8) Fig 4 J: It would be better to show the numbers of dendritic branch points or dendritic branch points per cell in % of control and not % deviation from control.
The effects caused by syndapin I, Cobl and both respectively, range from approx. 17-105% above control. One could of course also add 100% and report them as 117-205% vs. control=100%. However, we think that the effects are better visualized, if control is simply base line of the graph and therefore prefer deviation from control. We hope that the reviewer agrees with us that it is easier for the reader to focus on the effects caused by the different transfections, if the 100%-socket of control is omitted and control is placed at the 0%-axis. 
Is the difference between GFP and GFP-Cobl & SdpI overeexpression significant?

The appropriate statistical test would be One Way ANOVA and not T-test.
Please also see our response to your comment on Figure 4I . The revised figure 4J now shows the results of One Way ANOVA tests.
9) Fig. 8 I, K, J, L: The empty pRNAT-RFP vector is not the appropriate control, a scrambled, non targeting control shRNA should be used and the phenotype should be rescued with RNAi resistant SdpI (the authors have used this construct in (Dharmalingam et al J. Neurosci. 2009).
We agree that whether indeed the mRNA of interest is specifically targeted by a given RNAi tool or whether it acts unspecifically should always be checked by 1) an alternative RNAi tool against the RNA of interest (should give rise to an identical phenotype), 2) by a not-effective RNAi tool against the gene of interest, and/or 3) by a random sequence not corresponding to the RNA of interest 4) a rescue of the RNAi phenotype(s) by coexpression of an RNAi-insensitive mutant of the protein of interest. We have established the RNAi tool directed against syndapin I to be specific in developing primary hippocampal neurons (i.e. in the same cellular systems as used in this study) by comparison to controls 2), 3) and 4). This is described in detail in Dharmalingam et al. (2009) , a reference cited in the manuscript. Thus, the syndapin I RNAi tool can be considered as well characterized. This also holds true for Cobl RNAi. In order to establish this tool, we conducted controls 1), 2), 3) and 4) and additionally looked at putative effects of different cell fillers for control purposes (Ahuja et al., 2007) . The pRNAT vector is frequently used as a control. It gives rise to a non-targeting random RNA sequence under the H1-promotor. Since a significant number of animals and embryos have to be sacrificed for each condition to be analyzed because the numbers of transfected cells per coverslip are always low or transfections with some constructs frequently fail completely, we hope that the reviewer will agree with us that repeating the specificity controls for the published and thoroughly established RNAi plasmids directed against syndapin I yet another time can be omitted for this study.
Is the SdpI overexpression phenotype dependent on Cobl?
We have tried to answer this by coexpressing Cobl RNAi. The current data do not provide any hints on a Cobl-dependence of the syndapin phenotype. However, firm negative answers require especially high n-numbers and we only obtained very low n-numbers of transfected cells in the various assays we conducted. We can therefore only suggest that the answer is NO but that the syndapin I overexpression phenotype largely is N-WASP/Arp2/3 complexdriven instead. This would be in line with the findings that the syndapin I overexpression phenotype can be suppressed completely by N-WASP RNAi and Cdc42 N17 coexpression (Dharmalingam et al., 2009 ). (Fig 8J) ), how can it suppress branching induced by Cobl?
10) Fig. 8 J,L: If SdpI is not required for dendritic branching (knockdown of SdpI does not reduce dendritic branching
The Cobl-induced branching is an overexpression effect, Cobl may well use syndapin I for it (i.e. syndapin CAN promote branching, as also seen from the syndapin I overexpression phenotype) but this does not necessarily mean that syndapin I -in contrast to dendrite formation ( Figure 8K ) -also is a crucial component in dendritic branch formation. It would be very interesting to analyze whether there are any factors that are partially functionally redundant with syndapin I. Prime candidates of course are the other syndapin isoforms. Figure 5S -W demonstrates that also syndapin II and syndapin III bind to Cobl directly and Figure S1 confirms that such interactions also occur in vivo by showing a Cobl/syndapin II interaction in heterologous CoIPs. These thoughts are now discussed in the revised manuscript.
Referee #3 (Remarks to the Author):
The Ahuja et al. (2007) and Kessel et al. (2010) , Kessels et al. (2010) We thank the reviewer for pointing out that the title of the original manuscript may be hard to understand -probably because in English "control" can be a noun and a verb (?). We hope that the reviewer is more contend with the revised title. It should be clearer and nevertheless still complies with the EMBO Journal restriction (100 characters). As "cell morphology" alone is not a process and thus Cobl cannot have functions in cell morphology, we were not able to follow the reviewer's suggestion but we believe we found another clear alternative and replaced "Cell Morphology Control" by "Cellular Morphogenesis".
manuscript "The functions of the actin nucleator cobl in cell morphology control critically depend on syndapin" by Schwintzer et al. characterizes the interaction of cobl with syndapins and the importance of this interaction for cell morphology. The presented data are interesting in terms of the link of cobl to syndapin and the functional implications of this interaction. The experimental evidence for cobl and syndapin interaction looks convincing and the experiments were performed carefully. This manuscript is based on findings reported in
The use of 'dramatic' attributes continues throughout the following text. I understand that the authors want to highlight the importance of their results, but the reader is a bit put off by the exaggerated wording. I strongly suggest that the authors tune down the tone and take out all the unnecessary filling phrases and attributes. This will not diminish the quality of data or the appreciation of the reader for the data.
We have no problems with toning down the wording of the manuscript. We are not native English speakers and thus mostly use phrases of description found in the literature (including in EMBO J.). We hope that the reviewer will be more content with the revised manuscript, in which we tried to find alternative wording or simply deleted as many adjectives and adverbs as possible that may be considered "dramatic". Also, the words "extensive in vitro and in vivo studies" quoted by the reviewer have been deleted from the concluding paragraph of the introduction. Apart from this, two remarks may be allowed: First, if Cobl RNAi leads to a reduction of dendrite branching by about 20% in a time frame from DIV4 to DIV6, then this is quite an impairment, as it has to be considered that what happened before DIV4 (or even before reduction of Cobl levels kick in) cannot be affected anymore. Second, if the average of Cobl-expressing cells has about twice as many dendrites than control cells, then this is an extreme change in cell morphology of primary hippocampal neurons. We think that these effects can be appreciated by looking at Figure 4 in our current manuscript.
Second the discussion must be condensed. The discussion has been significantly shortened in the revised manuscript. Please see our more specific comment on the concluding comment of the reviewer. Figure 3A -F report on the spatial overlap of Cobl and syndapin I in dissociated neurons kept in culture for 2 and 21 days, respectively, Figure 3 G-I shows immunohistological examinations of 55 µm brain slices. They show, in the intact brain, 1) that both proteins overlap in the CA3 region of the hippocampus. As seen from Figure S3 , this is not trivial because Cobl is not expressed everywhere in the brain; neither is syndapin I. This is mentioned in the revised manuscript. Please also see Supplemental Figure S3 .
2) that both proteins show similar patterns of localization. We noted in the text that it is interesting that both proteins "particularly localized in the perikarya and in the dendritic trees of pyramidal cells" -a basis for the functional analyses of dendritogenesis in hippocampal neurons shown in the following figures. We did for example not find any hints for enrichments of either Cobl or sydapin I in glia cells. As we are not quite sure, how we can clarify this further, we hope that the text of the manuscript makes this clear(er). (Fig. 5 there ... please compare!) . This certainly needs to be addressed and explained to the editor! As already highlighted in the general section of this reply (see above), we would like to sincerely apologize for the erroneous selection of a control image in Figure 4 that has already been used as an example for a control cell in a current review. It is very embarrassing that this image of all the control images has been included into a figure again and that we did not notice it during proof reading of the manuscript. We are very grateful that reviewer 3 noticed this embarrassing mistake despite the fact that the image was displayed in different orientations to accommodate lettering. It is of course not permissible to re-use images and we have therefore selected another control cell image in the revised Figure 4 . Thanks again for saving us from this embarrassing error!
The experiments shown in Fig. 6 First of all, thank you very much for pointing out the errors in the labelling of Figure 6 ! Both typos have been corrected in the revised Figure 6 . From the reviewer comment we conclude that we should probably explain better to the readers what is happening in the assay and why it was done. The assay is a reconstitution experiment, which uses the ability of syndapin to interact with lipid surfaces -a well-defined version of such surfaces are the surfaces of liposomes made of purified lipids -and then asks whether such lipid-attached syndapin would have the ability to recruit Cobl to the membranes. As true for all reconstitution experiments, we acknowledge that the experiments appears somewhat "artificial". However, it allowed us to demonstrate that syndapin I can indeed recruit Cobl to lipid surfaces and to reveal the molecular mechanisms behind this property, i.e. a combination of SH3 domain-mediated Cobl binding and of lipid binding by a syndapin part N-terminal of the SH3 domain (the F-BAR domain). The F-BAR domain is a dimeric lipid-binding moiety. The reviewer is correct, it is crucial that syndapin is dimerized via the lipid-binding F-BAR domain, F-BAR domains are strongly believed to bind to lipids in their dimeric form. In contrast to the F-BAR domain, the SH3 domain that is responsible for the interaction with Cobl cannot bind to lipids (Dharmalingam et al., 2009) . Thus, use of the SH3 domain leads to a failure in recruiting Cobl to lipid surfaces ( Figure 6 ). We hope that the revised manuscript describes this better.
We have corroborated the finding that syndapin I can recruit Cobl to lipid surfaces in the in vitro reconstitutions (Figure 6 ) by related reconstitutions of membrane-associate protein complexes in vivo (Figure 7) , by demonstrating that both Cobl and syndapin I float to plasma membrane fractions (revised Figure 7) , by visualizing Cobl at the plasma membrane in neurons (revised Figure 7) and by demonstrating that reduction of syndapin I impairs the cortical localization of Cobl in primary hippocampal neurons (revised Figure 7) . Fig. 7 The fractionation is based on a plasma membrane isolation procedure established in Kretzschmar et al. (1996) . This reference is now also cited in the results section. In order to improve the data shown in Figure 7 , we additionally probed the 12 fractions of the gradient with anti-IRTK antibodies and the distribution of this integral plasma membrane protein was similar to that of syndapin I and Cobl (revised Figure 7Q) . We furthermore added immunofluorescence analyses of primary hippocampal neurons that have been transfected with plasma membrane-targeted GFP with anti-Cobl antibodies. These experiments demonstrate that there is a good spatial overlap of both signals at the plasma membrane (revised Figure 7R-T) . The syndapin I RNAi tools we used and the knock-down that is achieved by using these tools has been firmly established in Dharmalingam et al. (2009) . This reference is now also cited in the results section of the revised manuscript. The knock-down obtained with this tool in primary hippocampal neurons 48 h after transfection was measured in quantitative evaluations using fluorescence labeling. The reduction of the anti-syndapin immunosignal measured for syndapin I RNAi was (at least) 50% of control (Dharmalingam et al., 2009 ; Figure S4 ). We had established the RNAi tool directed against syndapin I to be specific in developing primary hippocampal neurons (i.e. in the same cellular systems as used in this study) by quantitative comparisons to controls 2), 3) and 4) (Dharmalingam et al., 2009) . The fact that the syndapin RNAi tool has been established previously is now mentioned and the corresponding reference is now cited in the results section of the revised manuscript. The pRNAT vector is frequently used as a control. It gives rise to expression of GFP (cell filler) and of a non-targeting random RNA sequence. Since a significant number of animals and embryos have to be sacrificed for each and every condition to be analyzed because the numbers of transfected cells per coverslip are always low or transfections with some constructs frequently fail completely, we hope that the reviewer will agree with us that repeating the specificity controls for the published and thoroughly established RNAi plasmids directed against syndapin I yet another time can be omitted for this study. The wording may indeed be misinterpreted and/or may sound funny. Thank you for pointing this out. In the draft of the manuscript, the sentence originally contained more detailed information on the quantitative data (p-values) omitted during manuscript shortening in compliance with EMBO J. guidelines. The sentence has been deleted all together in the revised manuscript.
I don't know how to interpret
Discussion is way to long and should focus on the novel findings!
The discussion has been significantly shortened in the revised manuscript. It has been condensed from 1945 to 1345 words. The length reduction that has been accomplished despite the fact that extensive additional experimentation conducted during the revision work, which for example also led to novel functional aspects, had to be included in the revised version of the manuscript. We consider 1345 words to be a reasonable length for a discussion, as several scientific journals suggest discussions to maximally have a length of 1500 words. We hope that the reviewer appreciates the streamlining. The revised discussion now especially focusses on the findings of our study, as the reviewer suggested. We hope that the reviewers appreciate the further experimental work we added during the revision and the changes we made to the manuscript and are looking forward to hearing from you.
2nd Editorial Decision 19 May 2011
Many thanks for submitting the revised version of your manuscript EMBOJ-2010-76858R. It has now been seen again by all three referees, whose comments are enclosed below. As you will see, all the reviewers find the manuscript substantially improved and are now fully supportive of publication in the EMBO Journal. There are just a couple of minor points from their side, but I do have some additional issues from the editorial side.
Firstly, most of the gels and blots appear artificially highly contrasted, and I would ask you to replace the panels with lower contrast versions -in some cases, background bands/smears are hardly visible in the final figure versions you provide. Also, in figure 1 , it looks as though lanes have been spliced together: this is permissible as long as the lanes come from the same gel, but it does need to be clearly marked by a dividing line, and mentioned in the figure legend. In figures 1G and I, the control lanes (GST-Sdp I) seem to be identical in the two gels. Please can you clarify what has been done here, revise the figures appropriately and also send me the original scans of the gels?
Secondly, please can you combine all the supplementary information into a single PDF file? At the moment, some of the SI is included as part of the main text; this should be removed and a single PDF made for all the SI material.
Thirdly, we require Author Contributions and Conflict of Interest statements for all accepted manuscripts -can you add these to the manuscript text beneath the Acknowledgments section?
Many thanks and best wishes,
Editor
The EMBO Journal
REFEREE REPORTS
Referee #1 (Remarks to the Author):
Comments for Schwintzer et al I think the manuscript is significantly improved, and I recommend publication of this manuscript in the EMBO journal.
Minor point P11 Subheading should be changed to more simple, clear meaning one.
Referee #2 (Remarks to the Author):
In this revision the manuscript by Schwintzer et al has been significantly improved and all my concerns have been addressed. In particular the endogenous complex between Syndapin, Cobl and Arp3 and the functional cooperation between cobl and Arp2/3 in dendritogenesis is remarkable. Therefore, I recommend publication of the manuscript in the EMBO J.
The revised version, including additional data appears much more consistent than the previous version. In general the wording has improved and the discussion is now more appropriate.
